Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholinesterase inhibition: complexities in interpretation

M Lotti1

  • 1Istituto di Medicina del Lavoro, Università degli Studi di Padova, Italy.

Clinical Chemistry
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Fractionally Charged Particles in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2025
Same author

Observation of the <math> </math> decay.

The European physical journal. C, Particles and fields·2024
Same author

Observation of the ϒ(3S) Meson and Suppression of ϒ States in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Search for Narrow Trijet Resonances in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same author

Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.

Physical review letters·2024
Same author

Search for exotic decays of the Higgs boson to a pair of pseudoscalars in the <math></math> and <math></math> final states.

The European physical journal. C, Particles and fields·2024
Same journal

From Pooled Cohorts to PREVENT: A Perspective for Clinical Laboratorians.

Clinical chemistry·2026
Same journal

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
See all related articles

Measuring cholinesterase activity, specifically erythrocyte acetylcholinesterase (AChE), helps assess organophosphate and carbamate exposure. While plasma butyrylcholinesterase is sensitive, erythrocyte AChE reflects nervous system effects, despite variations.

Area of Science:

  • Biochemistry
  • Toxicology
  • Neuroscience

Background:

  • Cholinesterases are key biomarkers for assessing exposure to organophosphorus esters and carbamates.
  • Plasma butyrylcholinesterase inhibition indicates exposure but lacks known physiological function.
  • Erythrocyte acetylcholinesterase (AChE) measurement mirrors nervous system effects, despite unknown physiological role.

Purpose of the Study:

  • To elucidate the utility and complexities of measuring cholinesterase activity for toxicological assessments.
  • To compare the sensitivity and implications of plasma butyrylcholinesterase versus erythrocyte AChE inhibition.
  • To highlight factors influencing the interpretation of cholinesterase inhibition data.

Main Methods:

  • Review of existing literature on cholinesterase measurement and interpretation.

Related Experiment Videos

  • Analysis of the relationship between erythrocyte AChE inhibition and nervous system effects.
  • Consideration of pharmacokinetic and pharmacodynamic factors in enzyme inhibition assessment.

    • Main Results:

    • Plasma butyrylcholinesterase is highly sensitive to inhibitors, reflecting exposure.
    • Erythrocyte AChE inhibition serves as a surrogate for nervous system effects, though subject to significant variation.
    • Erythrocyte AChE inhibition often overestimates nervous system impact due to pharmacokinetics and enzyme aging.

    Conclusions:

    • Erythrocyte AChE measurement is valuable for monitoring neurotoxic effects of organophosphates and carbamates.
    • Accurate assessment requires considering inter- and intraindividual variability, timing of measurements, and enzyme reactivation.
    • Direct receptor effects by toxicants can also impair cholinergic transmission, independent of cholinesterase inhibition.